Kendall, David M.
MannKind Corporation (United States)
16 papers on CoChatORCID 0000-0003-1910-2587
Most cited papers
- Verified
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 1,177
- Verified
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Drucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., & Porter, L. (2008) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 1,070
- Verified
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
Blonde, L., Klein, E. J., Han, J., Zhang, B., Mac, S. M., Poon, T. H., Taylor, K. L., Trautmann, M. E., Kim, D. D., & Kendall, D. M. (2006) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 416
- Verified
One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients
Bunck, M. C., Diamant, M., Cornér, A., Eliasson, B., Malloy, J. L., Shaginian, R. M., Deng, W., Kendall, D. M., Taskinen, M.-R., Smith, U., et al. (2009) · Diabetes Care
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 388
- Verified · note
Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics
Calles-Escandón, J., Lovato, L. C., Simons-Morton, D. G., Kendall, D. M., Pop-Busui, R., Cohen, R. M., Bonds, D. E., Fonseca, V. A., Ismail-Beigi, F., Banerji, M. A., et al. (2010) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 160
- Verified
Binge eating and other psychopathology in patients with type II diabetes mellitus
Crow, S., Kendall, D., Praus, B., & Thuras, P. (2001) · International Journal of Eating Disorders
Eating Disorders and BehaviorsNutrition, Health and Food Behavior
Cited by 139
- Verified
Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy
Kendall, D. M., Rooney, D. P., Smets, Y. F. C., Salazar Bolding, L., & Robertson, R. P. (1997) · Diabetes
Diabetes Management and ResearchPancreatic function and diabetes
Cited by 134
- Verified
Consensus Report of the Coalition for Clinical Research—Self-Monitoring of Blood Glucose
Klonoff, D. C., Bergenstal, R., Blonde, L., Boren, S. A., Church, T. S., Gaffaney, J., Jovanovič, L., Kendall, D. M., Kollman, C., Kovatchev, B. P., et al. (2008) · Journal of Diabetes Science and Technology
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 74
- Verified
Exenatide once weekly for the treatment of type 2 diabetes
Malone, J., Trautmann, M., Wilhelm, K., Taylor, K., & Kendall, D. M. (2009) · Expert Opinion on Investigational Drugs
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 55
- Verified
RESTORED HYPOGLYCEMIC COUNTERREGULATION IS STABLE IN SUCCESSFUL PANCREAS TRANSPLANT RECIPIENTS FOR UP TO 19 YEARS AFTER TRANSPLANTATION1
Paty, B. W., Lanz, K., Kendall, D. M., Sutherland, D. E. R., & Paul Robertson, R. (2001) · Transplantation
Pancreatic function and diabetesDiabetes Management and Research
Cited by 53
- Verified
Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus
Simonson, G. D., & Kendall, D. M. (2005) · Coronary Artery Disease
Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases
Cited by 38
- Verified
Impact of Modem-Transferred Blood Glucose Data on Clinician Work Efficiency and Patient Glycemic Control
Bergenstal, R. M., Anderson, R. L., Bina, D. M., Johnson, M. L., Davidson, J. L., Solarz-Johnson, B., & Kendall, D. M. (2005) · Diabetes Technology & Therapeutics
Diabetes Management and ResearchDiabetes Management and Education
Cited by 37
- Verified
Comprehensive Pulmonary Safety Review of Inhaled Technosphere® Insulin in Patients with Diabetes Mellitus
McGill, J. B., Peters, A., Buse, J. B., Steiner, S., Tran, T., Pompilio, F. M., & Kendall, D. M. (2020) · Clinical Drug Investigation
Inhalation and Respiratory Drug DeliveryDiabetes Management and Research
Cited by 35
- Verified
Hypoglycaemia is reduced with use of inhaled Technosphere® Insulin relative to insulin aspart in type 1 diabetes mellitus
Seaquist, E. R., Blonde, L., McGill, J. B., Heller, S. R., Kendall, D. M., Bumpass, J. B., Pompilio, F. M., & Grant, M. L. (2020) · Diabetic Medicine
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 30
- Verified
Management of type 2 diabetes: the role of incretin mimetics
Stonehouse, A. H., Holcombe, J. H., & Kendall, D. M. (2006) · Expert Opinion on Pharmacotherapy
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 29
- Verified
Results of a 24-week trial of technosphere insulin versus insulin aspart in type 2 diabetes
Hoogwerf, B. J., Pantalone, K. M., Basina, M., Jones, M. C., Grant, M., & Kendall, D. M. (2021) · Endocrine Practice
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free